Ece Erenler

Ece Erenler

Medicine, Koç University, Istanbul, İstanbul, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
EFEva Falkensammer
Eva Falkensammer
Ece ErenlerEce Erenler
Ece Erenler
TJtruls erik Bjerklund Johansen
truls erik Bjerklund Johansen
LTLazaros Tzelves
Lazaros Tzelves
LSLaila Schneidewind
Laila Schneidewind
ZTZafer Tandogdu
Zafer Tandogdu
It remains unclear whether antibiotic prophylaxis (AP) should be recommended or discouraged in robot-assisted laparoscopic radical prostatectomy (RALP) for prostate cancer (PCa). The development of microbial resistance and side effects are risks of antibiotic use. This systematic review (SR) investigates the evidence base for AP in RALP. A systematic literature search was conducted until 12 January 2023, using Embase, MEDLINE, Cochrane CENTRAL, Cochrane CDSR (via Ovid) and CINAHL for studies reporting the effect of AP on postoperative infectious complications in RALP. Of 436 screened publications, 8 studies comprising 6378 RALP procedures met the inclusion criteria. There was no evidence of a difference in the rate and severity of infective complications within 30 days after RALP surgery between different AP protocols. No studies omitted AP. For patients who received AP, the overall occurrence of postoperative infectious complications varied between 0.6% and 6.6%. The reported urinary tract infection (UTI) rates varied from 0.16% (4/2500) to 8.9% (15/169). Wound infections were reported in 0.46% (4/865) to 1.12% (1/89). Sepsis/bacteraemia and hyperpyrexia were registered in 0.1% (1/1084) and 1.6% (5/317), respectively. Infected lymphoceles (iLC) rates were 0.9% (3 of 317) in a RALP cohort that included 88.6% pelvic lymph node dissections (PLND), and 3% (26 of 865) in a RALP cohort where all patients underwent PLND. Our findings underscore that AP is being administered in RALP procedures without scientifically proven evidence. Prospective studies that apply consistent and uniform criteria for measuring infectious complications and antibiotic-related side effects are needed to ensure the comparability of results and guidance on AP in RALP.

9 February 2026 in Colorectal Disease
Verified
Journal Article
Closed access
Ece ErenlerEce Erenler
Ece Erenler
MEMetincan Erkaya
Metincan Erkaya
MOMustafa Oruc
Mustafa Oruc
SKSalih Nafiz Karahan
Salih Nafiz Karahan
EGEmre Gorgun
Emre Gorgun